<?xml version="1.0" encoding="UTF-8"?>
<ref id="B14-vaccines-07-00074">
 <label>14.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Gray</surname>
    <given-names>E.S.</given-names>
   </name>
   <name>
    <surname>Moore</surname>
    <given-names>P.L.</given-names>
   </name>
   <name>
    <surname>Pantophlet</surname>
    <given-names>R.A.</given-names>
   </name>
   <name>
    <surname>Morris</surname>
    <given-names>L.</given-names>
   </name>
  </person-group>
  <article-title>N-Linked Glycan Modifications in gp120 of Human Immunodeficiency Virus Type 1 Subtype C Render Partial Sensitivity to 2G12 Antibody Neutralization</article-title>
  <source>J. Virol.</source>
  <year>2007</year>
  <volume>81</volume>
  <fpage>10769</fpage>
  <lpage>10776</lpage>
  <pub-id pub-id-type="doi">10.1128/JVI.01106-07</pub-id>
  <?supplied-pmid 17634239?>
  <pub-id pub-id-type="pmid">17634239</pub-id>
 </element-citation>
</ref>
